Cargando…
Sulfated non-anticoagulant heparin derivative modifies intracellular hemoglobin, inhibits cell sickling in vitro, and prolongs survival of sickle cell mice under hypoxia
Sickle cell disease (SCD) is an autosomal recessive genetic disease caused by a single point mutation, resulting in abnormal sickle hemoglobin (HbS). During hypoxia or dehydration, HbS polymerizes to form insoluble aggregates and induces sickling of red blood cells, which increases the adhesiveness...
Autores principales: | Abdulmalik, Osheiza, Darwish, Noureldien H. E., Muralidharan-Chari, Vandhana, Taleb, Maii Abu, Mousa, Shaker A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Fondazione Ferrata Storti
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8804574/ https://www.ncbi.nlm.nih.gov/pubmed/33567814 http://dx.doi.org/10.3324/haematol.2020.272393 |
Ejemplares similares
-
Clinical Implications of the Association of Fetal Hemoglobin with Peripheral Oxygen Saturation in Sickle Cell Disease
por: Abdulmalik, Osheiza, et al.
Publicado: (2017) -
A Triazole Disulfide Compound Increases the Affinity
of Hemoglobin for Oxygen and Reduces the Sickling of Human Sickle
Cells
por: Nakagawa, Akito, et al.
Publicado: (2018) -
An Investigation of Structure-Activity Relationships of Azolylacryloyl Derivatives Yielded Potent and Long-Acting Hemoglobin Modulators for Reversing Erythrocyte Sickling
por: Omar, Abdelsattar M., et al.
Publicado: (2020) -
Identification of a Small Molecule that Increases
Hemoglobin Oxygen Affinity and Reduces SS Erythrocyte Sickling
por: Nakagawa, Akito, et al.
Publicado: (2014) -
Metabolic Reprogramming in Sickle Cell Diseases: Pathophysiology and Drug Discovery Opportunities
por: Alramadhani, Dina, et al.
Publicado: (2022)